0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Please Wait... Processing your request... Please Wait.

Not a subscriber yet?

Since 1883, physicians and health care professionals around the world have turned to JAMA for groundbreaking research and insightful commentary from leaders across the broad spectrum of health care. Subscribe/Learn More

Current Highlights

Follow Us

Research

Featured article

Original Investigation | July 19, 2016 CME

Buprenorphine Implants for Opioid Dependence Among Abstinent Adults

This noninferiority trial compares the effects of implanted vs sublingual buprenorphine for sustaining abstinence among adults with opioid dependence who achieved abstinence after 6 months or more of sublingual buprenorphine treatment.
Editorial

Featured article

Original Investigation | July 19, 2016

Comparative Efficacy of Glucose-Lowering Drugs for Type 2 Diabetes

This network meta-analysis of randomized clinical trials compares the relative efficacy and safety of glucose-lowering drugs and insulin for reducing cardiovascular mortality in patients with type 2 diabetes.

Featured article

Original Investigation | July 19, 2016 CME

Gun Law Reforms and Firearm Deaths in Australia

This population epidemiology study uses government statistics to compare the number of mass fatal shootings, firearm deaths, and firearm-related and all-cause homicide and suicides before and after enactment of gun law reforms in Australia in 1996.
Editorial

Opinion

Featured article

Viewpoint | July 25, 2016 FREE ONLINE FIRST

Lessons From the ACA About Decreasing Unintended Pregnancy

This Viewpoint discusses Affordable Care Act provisions that eliminate financial barriers to use of long-acting reversible contraception and implications for unintended pregnancies.

Viewpoint | July 21, 2016 FREE ONLINE FIRST

Women’s Health and Abortion Rights

This Viewpoint discusses the impact of the Supreme Court's 2016 Whole Woman's Health vs Hellerstedt decision requiring states to provide evidence that burdens placed on abortion access are justified by legitimate health concerns.

Featured article

Viewpoint | July 18, 2016 FREE ONLINE FIRST

Workplace Violence in Health Care

This Viewpoint discusses workplace violence in health care, emphasizing the elements of effective interventions to prevent assaults and violence in health care settings.

Clinical Review & Education

Featured article

Review | July 19, 2016 CME

Diagnosis and Treatment of Cellulitis

This narrative review summarizes published evidence about the epidemiology, diagnosis, and treatment of cellulitis.

Medical News & Perspectives

Featured article

Medical News & Perspectives | July 15, 2016 FREE ONLINE FIRST

The FDA, e-Cigarettes, and Smoking Cessation

This Medical News feature discusses implications of the FDA’s new authority over e-cigarettes for adolescent and adult use of electronic and conventional cigarettes.

Featured article

Medical News & Perspectives | July 13, 2016 FREE ONLINE FIRST

National Academies Cautious on Gene Drive-Modified Organisms

This Medical News article discusses a 2016 National Academy of Science advisory report on gene drive–modified organisms.

Explore more articles:  Current Issue | Online First

Multimedia >

Author Interview

Author photo

Richard N. Rosenthal, MD discusses a randomized clinical trial demonstrating the efficacy of an implantable buprenorphine-releasing device for treating opioid use disorder.  

audio player

RELATED ARTICLE:

Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine A Randomized Clinical Trial

All Author Interviews >

JAMA Editor's Audio Summary

July 19, 2016

Burphenorphine for prevention of opioid relapse, gun law reform in Australia, cellulitis review, and more

audio player

Author Readings
Author photo

Reading by Graham McMahon, author of Advancing Continuing Medical Education


Latest Quiz

All Quizzes >

Image of quiz image

Arthralgia and Fevers in a Patient With Autoimmune Hepatitis

A 66-year-old man taking azathioprene for autoimmune hepatitis presented with a 2-day history of fevers, lethargy, polyarticular arthralgias, and tender erythematous papulonodular lesions on the extensor surfaces of his lower and upper extremities.

What would you do next?

From The JAMA Network

HIV Preexposure Prophylaxis for High-Risk Patients

JAMA Patient Page
Title

For your patients: Diabetes in Older People.

Past JAMA Patient Pages are available in English and Spanish.

A Piece of My Mind

Changing The Narrative

JAMA Medical Student Elective in Medical Editing

JAMA offers a 4-week elective in medical editing to third- and fourth-year US medical students. The elective is full-time and must be taken for academic credit. For information and an application, please email jamams@jamanetwork.org.

Image of JAMA forum logo

Medical News

Wearable Biosensors Studied for Clinical Monitoring and Treatment

Visualizing Health Policy

HIV Awareness and Testing, 2013 AND 2014

Image of Visualizing Healthcare

Physician Jobs